 |
- Gilead to buy Kite Pharma for about $11 billion MarketWatch
- Gilead to buy Kite for promising cancer therapies in $12 billion deal Reuters
- Gilead to pay $11.9 billion for cancer treatment developer Kite Los Angeles Times
- UPDATED: Diving deep into CAR-T, Gilead forges $12B buyout deal for Kite Pharma Endpoints NewsFull coverage
|
No comments: